Aruga Technologies is a cutting-edge brand that specializes in developing advanced prosthetic implants for patients with arterial complications. Founded in 2017 by a team of surgeons and engineers at the University of Pittsburgh, Aruga aims to provide better off-the-shelf solutions for patients in need. Through extensive research, the team discovered that natural surfaces remain cleaner due to the presence of wrinkles, which act as a mechanical repellant.

Leveraging breakthrough materials science, Aruga has successfully constructed synthetic surfaces with incorporated wrinkles, resulting in self-cleaning biomimetic prototypes. Aruga is currently focused on commercializing this technology for vascular graft and shunt implants. The brand collaborates with government labs, hospitals, and research organizations to ensure that their innovative solution reaches the public.

Led by a dedicated core team, including Chief Technical Officer Luka Pocivavsek MD PhD, Chief Executive Officer Joe Pugar PhD, and Board Director Tony Torres, Aruga is at the forefront of revolutionizing the field of prosthetic implants. Discover the future of prosthetics with Aruga Technologies, where groundbreaking innovation meets compassion for patients in need